Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (LSE/NYSE: HLN) covers the month of April 2025, with a report date of April 11, 2025. The filing serves as a notification and public disclosure under the UK Market Abuse Regulation regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs). Haleon operates as a global leader in consumer health with a portfolio spanning Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider share transactions rather than a financial performance report.
Material Changes and Transactions
The filing details two specific share transactions executed on April 9, 2025, on the London Stock Exchange (XLON) under the Company's Share Reward Plan:
- Adrian Morris (General Counsel): Acquired 35 Partnership Shares at £3.5941 per share and received 35 Matching Shares at £Nil. Total aggregated volume: 70 shares.
- Tamara Rogers (Chief Marketing Officer): Acquired 35 Partnership Shares at £3.5941 per share and received 35 Matching Shares at £Nil. Total aggregated volume: 70 shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The document is limited to the statutory disclosure of the PDMR transactions described above.
Investor Verification Checklist
- Verify the total number of shares held by Adrian Morris and Tamara Rogers post-transaction against previous filings.
- Confirm the terms of the Haleon Share Reward Plan regarding the matching share mechanism.
- Review the current market price of Haleon ordinary shares (ISIN: GB00BMX86B70) relative to the transaction price of £3.5941.
- Check for any subsequent filings regarding other PDMR transactions in the same period.